Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

Saarinen NM, W?rri A, Dings RP, Airio M, Smeds AI, M?kel? S. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int J Cancer. 2008 Sep 01; 123(5):1196-204.

View in: PubMed

subject areas

4-Butyrolactone
9,10-Dimethyl-1,2-benzanthracene
Angiogenesis Inhibitors
Animals
Antineoplastic Agents
Apoptosis
Butylene Glycols
Carcinogens
Cell Proliferation
Dietary Supplements
Estrogen Receptor alpha
Estrogen Receptor beta
Female
Furans
Gene Expression Regulation, Neoplastic
Humans
Lignans
Mammary Neoplasms, Experimental
Mice
Mice, Nude
Ovariectomy
Phytoestrogens
Rats
Receptors, Progesterone
Transplantation, Heterologous

authors with profiles

Ruud Dings